Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument

Psycho-Oncology

Volumn 17, Issue 4, 2008, Pages 338-346

  Wettergren, Lena ^a,b   Sprangers, M ^a,c   Bjorkholm M ^a,d   Langius Eklof A ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Red Cross University College   (Sweden)

Author keywords

Cancer; EORTC; Health related quality of life; Oncology; SEIQoL DW; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; INTERMETHOD COMPARISON; MALE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SCHEDULE FOR THE EVALUATION OF INDIVIDUAL QUALITY OF LIFE DIRECT WEIGHTING; SCORING SYSTEM; STANDARDIZATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PERSONALITY INVENTORY; PSYCHOMETRICS; QUALITY OF LIFE; REFERENCE VALUES; REMISSION INDUCTION; SICK ROLE; SICKNESS IMPACT PROFILE;

EID: 41949101010     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1240     Document Type: Article

References (42)

1. Gratwohl A, Baldomero H, Horisberger B et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100:2374-2386.
2. Deeg HJ. Delayed complications after bone marrow transplantation. In Bone Marrow Transplantation, Forman SJ, Blume KG, Thomas ED (eds.). Blackwell Scientific Publications: Boston, 1994; 538-544.
3. Sullivan KM, Mori M, Sanders J et al. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant 1992;10:127-134.
4. Larsen J, Nordstrom G, Ljungman P et al. Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantation. Cancer Nurs 2004; 27:55-64.
5. Hjermstad MJ, Loge JH, Evensen SA et al. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24:1219-1228.
6. Schulz-Kindermann F, Hennings U, Ramm G et al. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marrow Transplant 2002;29:341-351.
7. Prieto JM, Atala J, Blanch J et al. Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. Bone Marrow Transplant 2005;35: 307-314.
8. Wettergren L, Langius A, Björkholm M et al. Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation - a prospective study. Bone Marrow Transplant 1997;20:497-502.
9. Sherman AC, Simonton S, Latif U et al. Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplant 2004;33: 955-962.
10. Hjermstad M, Holte H, Evensen S et al. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplant 1999;24:911-918.
11. Baker F, Zabora J, Polland A et al. Reintegration after bone marrow transplantation. Cancer Pract 1999;7: 190-197.
12. Hjermstad MJ, Evensen SA, Kvaloy SO et al. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol 1999;17:706-718.
13. McQuellon R, Russell G, Rambo T et al. Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marrow Transplant 1998;21:477-486.
14. Watson M, Wheatley K, Harrison GA et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer 1999; 86:1231-1239.
15. O'Boyle CA. Assessment of quality of life in surgery. Br J Surg 1992;79(5):395-398.
16. Bowling A. Measuring Disease - A Review of Disease-Specific Quality of Life Measurement Scales. Open University Press: Buckingham, 1995.
17. Ruta DA, Garratt AM, Leng M et al. A new approach to the measurement of quality of life. The patient-generated index. Med Care 1994;32:1109-1126.
18. O'Boyle CA. The schedule for the evaluation of the individual quality of life (SEIQoL). Int J Ment Health 1994;23:3-23.
19. Hiekey AM, Bury G, O'Boyle CA et al. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. Br Med J 1996;313:29-33.
20. Browne JP, O'Boyle CA, McGee HM et al. Development of a direct weighting procedure for quality of life domains. Qual Life Res 1997;6:301-309.
21. O'Boyle CA, McGee H, Hickey A et al. Individual quality of life in patients undergoing hip replacement. Lancet 1992;339(May 2): 1088-1091.
22. Bowling A. Measuring Health: A Review of Quality of Life Measurement Scales (3rd edn). Open University Press: Buckingham, 2005.
23. Calman KC. Quality of life in cancer patients - an hypothesis. J Med Ethics 1984;10:124-127.
24. Cella DF. Quality of life: the concept. J Palliat Care 1992; 8(3):8-13.
25. Wettergren L, Björkholm M, Axdorph U et al. Individual quality of life in long-term survivors of Hodgkin's lymphoma - a comparative study. Qual Life Res 2003;12:545-554.
26. Bowling A. What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life. Soc Sci Med 1995;41: 1447-1462.
27. Wettergren L, Björkholm M, Langius-Eklöf A. Validation of an extended version of the SEIQoL-DW in a cohort of Hodgkin lymphoma' survivors. Qual Life Res 2005;14:2331-2335.
28. Wettergren L, Björkholm M, Axdorph U et al. Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 2004;13:1369-1379.
29. Waldron D, O'Boyle CA, Kearney M et al. Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol 1999;17:3603-3611.
30. Montgomery C, Pocock M, Titley K et al. Individual quality of life in patients with leukaemia and lymphoma. Psycho-Oncology 2002; 11:239-243.
31. Frick E, Borasio GD, Zehentner H et al. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psycho-Oncology 2004;13:116-124.
32. Aaronson NK, Ahmedzai S, Bergman B et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
33. King MT. The interpretation of scores from the EORTC Quality of Life Questionnaire QLQ-C30. Qual Life Res 1996;5:555-567.
34. Kaasa S, Bjordal K, Aaronson N et al. The EORTC core Quality of Life Questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995;31A: 2260-2263.
35. Michelson H, Bolund C, Nilsson B et al. Health-related quality of life measured by the EORTC QLQ-C30 - reference values from a large sample of the Swedish population. Acta Oncol 2000; 39:477-484.
36. Hjermstad MJ, Fayers PM, Bjordal K et al. Using reference data on quality of life - the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 1998; 34: 1381-1389.
37. Osoba D, Rodrigues G, Myles J et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139-144.
38. Watson M, Buck G, Wheatley K et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004;40:971-978.
39. Thornton AA. Perceiving benefits in the cancer experience. J Clin Psychol Med Settings 2002;9:153-165.
40. Tomich PL, Helgeson VS, Nowak Vache EJ. Perceived growth and decline following breast cancer: a comparison to age-matched controls 5-years later. Psycho-Oncology 2005;14:1018-1029.
41. Widows MR, Jacobsen PB, Booth-Jones M et al. Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol 2005;24:266-273.
42. Sharpe L, Butow P, Smith C et al. Changes in quality of life in patients with advanced cancer: evidence of response shift and response restriction. J Psychosom Res 2005;58:497-504.